Fig 4 - حسب Maryann S. Watson (16879881)

Velocity of postural sway in the four sensory conditions before and after napping. حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the beta band (13-21 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the fast beta band (22-30 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the alpha band (8-12 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the theta band (4-7 Hz). حسب Hui-Ya Chen (13919141)

Average EEG activity (power in %) relative to the condition of “eyes open, firm surface, before nap” in the gamma band (31-50 Hz). حسب Hui-Ya Chen (13919141)

Frequency of postural sway in the four sensory conditions before and after napping. حسب Hui-Ya Chen (13919141)

Differential expression of growth-promoting and growth-inhibiting genes optimizes biomass production and seed yield. حسب Sreya Das (20531295)

Co-infected cells express both KSHV and EBV genes <i>in vitro</i> necessary for their survival and growth. حسب Mitchell Hayes (5334887)

Effect of fasudil on clinical outcomes of pulmonary hypertension: a systematic review and meta-analysis حسب Wanying Bao (19665769)

"…</p> <p>Inclusion of 3269 Group-3 PH patients demonstrated that Fasudil increased effective events, forced expiratory volume in one second (FEV₁), 6-minute walking distance (6MWD) and arterial partial pressure of oxygen (PaO₂), and decreased mean pulmonary artery pressure (mPAP) and pulmonary artery systolic pressure (PASP); Inclusion of 197 Group-2 PH patients suggested that Fasudil increased 6MWD and PaO₂, and decreased PASP. …"

Dynamics of PIF4 protein accumulation and autoinhibition in response to temperature. حسب Sreya Das (20531295)

Absolute and relative cardiomyopathy and myocarditis DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative ischaemic heart disease DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative stroke DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative overall CVD DALYs rate attributable to 2^nd-level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative atrial fibrillation and flutter DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative hypertensive heart disease DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative aortic aneurysm DALYs rate attributable to 2^nd level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)

Absolute and relative overall CVD DALYs rate attributable to 1^st-level risk factors in Chile. حسب Camilo Briones-Valdivieso (21567535)